ECAS correlation with metabolic alterations on FDG-PET imaging in ALS

Juliette Foucher Linn Öijerstedt Anikó Lovik Jiawei Sun Muhammad-Al-Mustafa Ismail Stefan Sennfält Irina Savitcheva Ulrika Estenberg Marco Pagani Fang Fang Joana B. Pereira Caroline Ingre 1 Department of Clinical Neuroscience,Karolinska Institutet,Stockholm,Sweden2 Department of Neurology,ME Neurology,Karolinska University Hospital,Stockholm,Sweden3 Unit of Integrative Epidemiology,Institute of Environmental Medicine,Karolinska Institutet,Stockholm,Sweden4 Methodology and Statistics Unit,Institute of Psychology,Leiden University,Leiden,The Netherlands5 Medical Radiation Physics and Nuclear Medicine Imaging,Section for Nuclear Medicine,Karolinska University Hospital,Stockholm,Sweden,and6 Institute of Cognitive Sciences and Technologies,Italian National Research Council,Rome,Italy
DOI: https://doi.org/10.1080/21678421.2024.2361695
2024-06-05
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Abstract:Background: Cognitive impairment is observed in up to 50% of patients with amyotrophic lateral sclerosis (ALS). The Edinburgh Cognitive and Behavioral ALS Screen (ECAS) is an ALS-specific multi-domain screening tool. Few studies have examined the relationship between ECAS scores and [ 18 F]fluorodeoxyglucose positron emission tomography ([ 18 F]FDG-PET) findings. Objective: To assess the relationship between ECAS scores and glucose metabolism patterns on [ 18 F]FDG -PET images in ALS. Methods: We collected [ 18 F]FDG-PET images from 65 patients with ALS and 39 healthy controls. ECAS scores were collected on all patients and we calculated the correlation to [ 18 F]FDG-PET in order to investigate the potential links between cognition and glucose metabolism. Results: We observed hypometabolism in the frontal cortex, insula, and limbic system, together with hypermetabolism in the cerebellum in patients with ALS compared to controls. A lower ECAS total score was associated with lower glucose metabolism in the right orbitofrontal gyrus and higher glucose metabolism in lateral occipital, medial occipital, and cerebellar regions, among patients with ALS. Similar results, although less widespread, were observed in the analyses of ECAS ALS-specific scores. Conclusions: The metabolic patterns in [ 18 F]FDG -PET show that changes in the glucose metabolism of corresponding areas are related to cognitive dysfunction in ALS, and can be detected using the ECAS.
clinical neurology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to evaluate the relationship between the Edinburgh Cognitive and Behavioral ALS Screen (ECAS) score and the glucose metabolism pattern detected by [18F]fluorodeoxyglucose positron - emission tomography ([18F]FDG - PET) imaging in patients with ALS (amyotrophic lateral sclerosis). Specifically, the researchers want to explore whether cognitive dysfunction (assessed by ECAS) is associated with changes in glucose metabolism in specific brain regions in ALS patients. ### Background - The proportion of cognitive impairment observed in ALS patients is as high as 50%. - ECAS is a multi - domain screening tool specifically for ALS patients. - Although a small number of studies have explored the relationship between ECAS scores and [18F]FDG - PET results, research in this area is still relatively limited. ### Objectives - **Primary objective**: To evaluate the relationship between ECAS scores and the glucose metabolism pattern in [18F]FDG - PET images of ALS patients. - **Secondary objective**: To explore the potential link between cognitive dysfunction and metabolic changes in specific brain regions. ### Methods - **Study subjects**: [18F]FDG - PET images of 65 ALS patients and 39 healthy controls were collected. - **Cognitive assessment**: All patients were given an ECAS score. - **Data analysis**: The correlation between ECAS scores and [18F]FDG - PET images was calculated to explore the potential link between cognitive function and glucose metabolism. ### Results - **Metabolic changes**: Compared with the healthy control group, ALS patients showed hypometabolism in the frontal cortex, insula, and limbic system, and hypermetabolism in the cerebellum and occipital cortex. - **Relationship between ECAS and metabolism**: A lower total ECAS score was associated with hypometabolism in the right orbitofrontal gyrus and hypermetabolism in the occipital, medial occipital, and cerebellar regions. Similar results were also observed in the analysis of ECAS ALS - specific scores, although to a lesser extent. ### Conclusions - The metabolic pattern shown by [18F]FDG - PET indicates that changes in glucose metabolism in the corresponding brain regions are related to cognitive dysfunction in ALS. - These findings support the continuity of cognitive dysfunction in ALS, across the entire spectrum from pure motor dysfunction to frontotemporal dementia. ### Keywords - Amyotrophic lateral sclerosis (ALS) - ECAS - Neuropsychology - Imaging - FDG - PET ### Significance - This study provides a new perspective for understanding cognitive dysfunction in ALS patients, especially by combining ECAS scores and [18F]FDG - PET imaging data. - These findings are helpful for further research on the potential value of these metabolic patterns in the early diagnosis and prognostic evaluation of ALS.